Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma

NCT04063189 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen

Sponsor

The First Hospital of Jilin University